1. Home
  2. CZFS vs CRNX Comparison

CZFS vs CRNX Comparison

Compare CZFS & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Financial Services Inc.

CZFS

Citizens Financial Services Inc.

HOLD

Current Price

$60.31

Market Cap

288.7M

Sector

Finance

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$33.65

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CZFS
CRNX
Founded
1984
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.7M
3.9B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
CZFS
CRNX
Price
$60.31
$33.65
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$74.78
AVG Volume (30 Days)
5.9K
1.0M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.32%
N/A
EPS Growth
30.26
N/A
EPS
7.62
N/A
Revenue
$9,881,000.00
$1,039,000.00
Revenue This Year
N/A
$722.66
Revenue Next Year
$2.64
$183.79
P/E Ratio
$7.90
N/A
Revenue Growth
2.82
N/A
52 Week Low
$49.99
$24.10
52 Week High
$69.30
$57.99

Technical Indicators

Market Signals
Indicator
CZFS
CRNX
Relative Strength Index (RSI) 44.08 29.20
Support Level $58.03 $33.23
Resistance Level $63.69 $37.23
Average True Range (ATR) 2.13 1.62
MACD 0.03 0.13
Stochastic Oscillator 38.36 8.33

Price Performance

Historical Comparison
CZFS
CRNX

About CZFS Citizens Financial Services Inc.

Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: